Longitudinal fibrosis-4 monitoring: A promising approach for hepatocellular carcinoma risk stratification in treatment-naïve chronic hepatitis C
World Journal of Gastrointestinal Oncology · 15.11.2026 · 18 (11)
DOI: 10.4251/wjgo.120525 ↗Kurz gefasst
Fachartikel in der Zeitschrift World Journal of Gastrointestinal Oncology, online erschienen am 15.11.2026. Verfasst von Hai Nguyen Ngoc Dang und 5 weiteren Autor:innen. Die Arbeit nennt 34 Literaturangaben.
Abstract (Originalsprache)
A substantial proportion of patients with chronic hepatitis C virus infection remain untreated worldwide, sustaining a cumulative and age-dependent risk of hepatocellular carcinoma, particularly in resource-limited settings. Conventional risk stratification relies on baseline “snapshots” of fibrosis stage and single-time-point biomarkers, which may fail to capture the dynamic biology of fibrogenesis and carcinogenesis. In a long-term retrospective cohort of treatment-naïve patients with chronic hepatitis C virus published in the World Journal of Gastrointestinal Oncology , Li et al reported that a 3-year increase in the fibrosis-4 (FIB-4) index (ΔFIB-4 ≥ 1.0) independently predicted subsequent hepatocellular carcinoma (adjusted hazard ratio approximately 2.7), with the increasing trajectory group exhibiting a high long-term cumulative incidence. These findings suggest that longitudinal biomarker trajectories may refine long-term risk stratification beyond baseline staging, although the timing and actionable thresholds require prospective validation. Biologically, progressive increases in FIB-4 may reflect ongoing extracellular matrix remodeling, inflammation-driven microenvironmental shifts, and vascular alterations that promote tumor development. However, interpretation must account for age-related score drift, biological variability, and nonhepatic confounding. We propose a pragmatic framework integrating threshold-crossing and slope-based monitoring, combining serial FIB-4 with alpha-fetoprotein and key demographic modifiers. High-risk longitudinal patterns may warrant the use of confirmatory elastography and the consideration of intensified surveillance, pending prospective validation. Prospective studies are needed to standardize longitudinal cutoffs and validate clinical implementation.
Zitieren
APA
Dang, H. N. N., Luong, T. V., Vu, H. M., Nguyen, K. Y., Xuan, H. T., & Thi, B. N. H. (2026). Longitudinal fibrosis-4 monitoring: A promising approach for hepatocellular carcinoma risk stratification in treatment-naïve chronic hepatitis C. World Journal of Gastrointestinal Oncology, 18(11). https://doi.org/10.4251/wjgo.120525
Vancouver
Dang HNN, Luong TV, Vu HM, Nguyen KY, Xuan HT, Thi BNH. Longitudinal fibrosis-4 monitoring: A promising approach for hepatocellular carcinoma risk stratification in treatment-naïve chronic hepatitis C. World Journal of Gastrointestinal Oncology. 2026;18(11). doi:10.4251/wjgo.120525
BibTeX
@article{Dang2026,
author = {Dang, Hai Nguyen Ngoc and Luong, Thang Viet and Vu, Hung Minh and Nguyen, Kim Yen and Xuan, Hung Tran and Thi, Bich Ngoc Hoang},
title = {Longitudinal fibrosis-4 monitoring: A promising approach for hepatocellular carcinoma risk stratification in treatment-naïve chronic hepatitis C},
journal = {World Journal of Gastrointestinal Oncology},
year = {2026},
volume = {18},
number = {11},
doi = {10.4251/wjgo.120525}
}
EUVIMED